New Orleans New Orleans

From Evidence to Impact: Key Takeaways from ACC.26

ACC Congress 2026 | From practice-changing trials to the rise of AI and ongoing challenges in workforce and health equity, ACC.26 offered a compelling look at the future of cardiology. In this interview, Christopher M. Kramer, president of the American College of Cardiology (ACC) 2025–2026, shares key insights on the major late breaking sessions, great debates and standout moments of this year's congress in New Orleans.

By:

Romy Martínez

HERZMEDIZIN editorial team

 

 

2026-04-08

Image source (image above): pisaphotography / Shutterstock.com

Take-aways

  • Experience in imaging innovation highlights the growing role of AI, especially in cardiovascular imaging workflows, and underscores the importance of adapting training to multi-modality and AI-integrated practice.
  • Key clinical trials reinforced major advances: catheter-delivered thrombolysis for pulmonary embolism showed long-term benefit, and aggressive LDL reduction (including with PCSK9 inhibitors) continues to improve cardiovascular outcomes.
  • AI and digital health emerged as dominant themes, with expanding applications in wearables, biometrics, workflow optimization, and imaging — signaling a transformative impact on current and future cardiovascular care.

To the overview page ACC Congress 2026

Related news

Heart Failure 2026 | CARDIO-TTRansform: Stellenwert des TTR-Silencers bei ATTR-Amyloidose mit Kardiomyopathie in einer Real-World-Kohorte. Von Dr. L. Schlender.

Heart Failure 2026 | MAPLE-HCM: Die Subanalyse untersuchte die Dosis-Wirkungs-Beziehung von Aficamten versus Metoprolol. Von Dr. L. Schlender.

EAS Congress 2026 | Heart-2: Interimsanalyse der Phase-1-Studie mit Erwachsenen mit heterozygoter familiärer Hypercholesterinämie. Von Prof. U. Laufs.